Hepatitis Archives - MPR


Harvoni, Sovaldi Approved for Younger Patients With Chronic HCV

The Food and Drug Administration (FDA) has approved Harvoni (ledipasvir and sofosbuvir; Gilead) and Sovaldi (sofosbuvir; Gilead) for use in younger patients with chronic hepatitis C virus (HCV). Specifically, Harvoni is now indicated for use in patients 3 years of age and older with: HCV genotypes 1, 4, 5, or 6 infection without cirrhosis or…